|
AP20730a-ev
|
Abcepta, Inc.
|
C1QBP [N-term] [RB48595], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP20730a
|
Abcepta, Inc.
|
C1QBP [N-term] [RB48595], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP15024a-ev
|
Abcepta, Inc.
|
S. Aureus Delta Hemolysin [RB33802], Rabbit Polyclonal Antibody
|
S. Aureus
|
WB
|
|
|
AP15024a
|
Abcepta, Inc.
|
S. Aureus Delta Hemolysin [RB33802], Rabbit Polyclonal Antibody
|
S. Aureus
|
WB
|
|
|
HY-128773A-10mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-100mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-25mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-5mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-128773A-50mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-18169-10mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-18169-5mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-18169-1mL
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-W142092-10mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-100mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-25mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-50mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-111023-1mg
|
MedChemexpress LLC
|
Nemonoxacin (malate) [CAS 951163-60-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-111023-10mg
|
MedChemexpress LLC
|
Nemonoxacin (malate) [CAS 951163-60-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-111023-25mg
|
MedChemexpress LLC
|
Nemonoxacin (malate) [CAS 951163-60-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-111023-5mg
|
MedChemexpress LLC
|
Nemonoxacin (malate) [CAS 951163-60-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-111071-100mg
|
MedChemexpress LLC
|
Nilofabicin [CAS 934628-27-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-111071-50mg
|
MedChemexpress LLC
|
Nilofabicin [CAS 934628-27-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N5127-100mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N5127-25mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N5127-50mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
